Nexien BioPharma (NXEN) Short Interest Ratio & Short Volume

Short interest is the volume of Nexien BioPharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 600 shares of NXEN short. Learn More on Nexien BioPharma's current short interest.

Nexien BioPharma saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 600 shares, a decrease of 83.8% from the previous total of 3,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nexien BioPharma: Eterna Therapeutics Inc. (1.53%), Vaccinex, Inc. (9.11%), Orgenesis Inc. (0.29%), Upexi, Inc. (22.07%), TFF Pharmaceuticals, Inc. (5.55%), Portage Biotech Inc. (3.42%), BioCardia, Inc. (3.17%), Intellipharmaceutics International Inc. (0.00%), Biofrontera Inc. (12.12%), Ensysce Biosciences, Inc. (43.43%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling NXEN is an investing strategy that aims to generate trading profit from Nexien BioPharma as its price is falling. NXEN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nexien BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NXEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXEN, twice per month. The most recent reporting period available is October, 31 2024.